| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 08/07/2008 | WO2007079052A3 Novel immunologically active peptide fragments of a proline-rich polypeptide isolated from colostral mammalian fluids for treatment of viral and non-viral diseases or diseased conditions |
| 08/07/2008 | WO2006107786A3 Improved stably tethered structures of defined compositions with multiple functions or binding specificities |
| 08/07/2008 | WO2006022409A8 Hazardous substance scavenger and application apparatus and application method therefor |
| 08/07/2008 | US20080188640 Immunodeficiency recombinant poxvirus |
| 08/07/2008 | US20080188469 Vaccination |
| 08/07/2008 | US20080188425 Dihydroouabain-like factor and diagnostic & therapeutic compositions and methods |
| 08/07/2008 | US20080188420 Daily intravenous administration of VEGFR1R2-Fc Delta C1 or coadministration with a cytotoxic, chemotherapeutic or antigrowth agent, while gradually decreasing dosage of the antagonist; colorectal cancer |
| 08/07/2008 | US20080188419 Method of administering and using VEGF inhibitors for the treatment of human cancer |
| 08/07/2008 | US20080188418 Method of administering and using VEGF inhibitors for the treatment of human cancer |
| 08/07/2008 | US20080188410 Apoptosis-inducing polypeptides |
| 08/07/2008 | US20080187961 Polynucleotides encoding signal peptide-containing molecules |
| 08/07/2008 | US20080187933 Viral DNA fragments for use as probes in detecting viral infection |
| 08/07/2008 | US20080187577 Immunogenic compositions comprising progastrin and uses thereof |
| 08/07/2008 | US20080187559 Solvent extraction of lipids from cancer cells; mixture of cancer cell particles and carrier that induce immunology stimulation |
| 08/07/2008 | US20080187558 High speed dissolving dosage form; administering to mucous membranes;matric containing gelating, starch nd mannitol |
| 08/07/2008 | US20080187557 Vaccine Against Pandemic Strains Of Influenza Viruses |
| 08/07/2008 | US20080187556 Using human rabies virus immunoglobulins; viricide against human papillomarvirus; side effect reduction; antiaging and oxidation resistance |
| 08/07/2008 | US20080187555 Stable oil in water emulsion containing deactivated immunogen such as Mycoplasma or circovirus with mineral and nonionic surfactant ; induce immunology response |
| 08/07/2008 | US20080187554 Solubilizing t-helper epitopes in buffer comprising succinic acid and manitol for use in immunoglobulin to prevent and treat human immunodeficiency viral infection; vaccines; immunotherapy |
| 08/07/2008 | US20080187553 Immunstimulating lipid formulation |
| 08/07/2008 | US20080187552 Novel vaccine composition and use of surfactants as adjuvants of immunity |
| 08/07/2008 | US20080187551 Nucleotide sequences coding oncogenic polypeptides for use in generating vaccines to prevent and treat cell proliferative disorders; genetic vaccines |
| 08/07/2008 | US20080187550 Using bacterial dnaJ chaperone protein sequences as agent to enhance immune respone; for use in treatment and prevention of arthritic inflammation |
| 08/07/2008 | US20080187549 Using whole live sperm as antigen to generate immunoglobulins which prevent and/or control conception; contraceptives |
| 08/07/2008 | US20080187548 Ny-Eso-1 Peptides Which Bind To Class II Molecules And Uses Thereof |
| 08/07/2008 | US20080187547 Immune receptor translocation associated-5 (IRTA-5 ) protein specific immunoglobulin for use in diagnosis, prevention and treatment of B cell malignancies |
| 08/07/2008 | US20080187546 Method for Replicating Influenza Virus in Culture |
| 08/07/2008 | US20080187545 Cytomegalovirus surface protein complex for use in vaccines and as a drug target |
| 08/07/2008 | US20080187544 Treating and evaluating inflammatory disorders |
| 08/07/2008 | US20080187543 Using antimyostatin immunoglobulin to improving tissue wound healing |
| 08/07/2008 | US20080187542 Herpesvirus entry mediator (HVEM) specific immunoglobulin for use in treatment and prevention of transplant rejection, graft-versus-host and transplant autoimmune diseases |
| 08/07/2008 | US20080187541 Helicobacter pylori adhesin binding group antigen |
| 08/07/2008 | US20080187540 Osteoclastogenesis inhibitory factor-binding molecule (OBM) specific immunoglobulin for use inhibiting osteoclast inhibitory factor (OCIF) binding activity and treating bone disorders |
| 08/07/2008 | US20080187539 Chemokine receptor specific monoclonal antibody for prevention and treatment of human immunodeficiency infection |
| 08/07/2008 | US20080187538 Posh nucleic acids, polypeptides and related methods |
| 08/07/2008 | US20080187537 Using immunodeficient animals to generate cancer cell infiltrating lymphocytes; immunotherapy; tissue targeted therapy |
| 08/07/2008 | US20080187536 Immunological modulation of insulin-like growth factor 1 for cancer prevention/treatment and prolonging longevity |
| 08/07/2008 | US20080187535 Vaccine |
| 08/07/2008 | US20080187534 Anti-vegf antibodies |
| 08/07/2008 | US20080187533 Treatment with anti-erbb2 antibodies |
| 08/07/2008 | US20080187532 Compositions and methods for diagnosing and treating cancer |
| 08/07/2008 | US20080187531 Antibodies directed to tumor necrosis factor and uses thereof |
| 08/07/2008 | US20080187530 Novel Agents and Use Thereof |
| 08/07/2008 | US20080187529 Anti-human vegf receptor flt-1 monoclonal antibody |
| 08/07/2008 | US20080187528 Anti-tsg101 antibodies and their uses for treatment of viral infections |
| 08/07/2008 | US20080187527 Novel endometriosis-associated gene |
| 08/07/2008 | US20080187515 Use of Immunoconjugates to Enhance the Efficacy of Multi-Stage Cascade Boosting Vaccines |
| 08/07/2008 | US20080187513 Treatment of Solid Cancers |
| 08/07/2008 | US20080187508 Treatment of Golmerular Basement Membrane Disease Involving Matrix Metalloproteinase-12 |
| 08/07/2008 | DE10132669B4 Pharmakologische Zubereitung aus einem nanopartikulären mesomorphen Polyelektrolyt-Lipid-Komplex und mindestens einem Wirkstoff Pharmacological preparation of a nanoparticulate mesomorphic polyelectrolyte-lipid complex and at least one active ingredient |
| 08/07/2008 | CA2677163A1 Humanized antibodies against cxcr3 |
| 08/07/2008 | CA2676995A1 Sugar immunogens |
| 08/07/2008 | CA2676838A1 Allergen-binding ige monoclonal antibodies and method for preparing hypoallergens |
| 08/07/2008 | CA2676699A1 An hbv vaccine and a process of preparing the same |
| 08/07/2008 | CA2676689A1 Recombinant bicistronic flavivirus vectors |
| 08/07/2008 | CA2676624A1 Prevention of allergic sensitization |
| 08/07/2008 | CA2676555A1 Detection of influenza virus |
| 08/07/2008 | CA2676402A1 Use of a first house dust mite group 2 allergen for treating allergy to a second house dust mite group 2 allergen |
| 08/07/2008 | CA2676129A1 Methods of modulating immune function |
| 08/07/2008 | CA2675639A1 Modulators of sclerostatin biniding partners for treating bone-related disorders |
| 08/07/2008 | CA2675355A1 Papillomavirus vaccine |
| 08/07/2008 | CA2659275A1 Chimeric influenza virus-like particles |
| 08/07/2008 | CA2657955A1 Chimeric virus-like particles |
| 08/07/2008 | CA2655903A1 Ilt3 binding molecules and uses therefor |
| 08/07/2008 | CA2651866A1 Sialoadhesin-related compositions and methods |
| 08/06/2008 | EP1953173A1 Secreted and transmembrane polypeptides and nucleic acids endoding the same |
| 08/06/2008 | EP1952825A1 Nanometer targeted drug for magneto-thermotherapy of malignant tumors |
| 08/06/2008 | EP1952802A2 Buccal, polar and non-polar spray or capsule |
| 08/06/2008 | EP1951892A1 Antibody treatment of alzheimer's and related diseases |
| 08/06/2008 | EP1951891A1 Cancer antigen mage-a9 and uses thereof |
| 08/06/2008 | EP1951886A2 Fed batch culture methods for streptococci |
| 08/06/2008 | EP1951882A2 Nucleic acids encoding tgev and prrsv sequences for improved expression of prrsv sequences |
| 08/06/2008 | EP1951865A1 Stabilizing formulations for recombinant viruses |
| 08/06/2008 | EP1951760A2 Human monoclonal antibody human cd134 (ox40) and methods of making and using same |
| 08/06/2008 | EP1951759A2 Anti-egfr antibodies |
| 08/06/2008 | EP1951756A2 Anti-myostatin antibodies |
| 08/06/2008 | EP1951755A2 Anti-myostatin antibodies |
| 08/06/2008 | EP1951336A2 Method to inhibit proliferation and growth of metastases |
| 08/06/2008 | EP1951332A1 Reduction of restenosis |
| 08/06/2008 | EP1951306A2 Reduction and prevention of cell-associated hiv transepithelial migration, microbides and other formulations and methods |
| 08/06/2008 | EP1951305A1 Immunoglobulin fusion protein formulations |
| 08/06/2008 | EP1951304A1 Method for treating joint damage |
| 08/06/2008 | EP1951303A2 Therapy with cd4 binding peptides and radiation |
| 08/06/2008 | EP1951302A2 Influenza vaccine with reduced amount of oil-in-water emulsion as adjuvant |
| 08/06/2008 | EP1951301A2 Emulsions with free aqueous-phase surfactant for adjuvanting split influenza vaccines |
| 08/06/2008 | EP1951300A2 Changing th1/th2 balance in split influenza vaccines with adjuvants |
| 08/06/2008 | EP1951299A1 Influenza vaccines including combinations of particulate adjuvants and immunopotentiators |
| 08/06/2008 | EP1951298A1 Adjuvanted influenza vaccines including cytokine-inducing agents |
| 08/06/2008 | EP1951297A2 Adenoviral vector-based foot-and-mouth disease vaccine |
| 08/06/2008 | EP1951296A2 Cell-derived viral vaccines with low levels of residual cell dna |
| 08/06/2008 | EP1951295A1 Vaccines |
| 08/06/2008 | EP1951294A1 Immunomodulatory properties of multipotent adult progenitor cells and uses thereof |
| 08/06/2008 | EP1951288A2 Method of enhancing the immune response to a vaccine |
| 08/06/2008 | EP1951281A2 Wt1 hla class ii-binding peptides and compositions and methods comprising same |
| 08/06/2008 | EP1951222A2 Method of treating breast cancer using 17-aag or 17-ag or a prodrug of either in combination with a her2 inhibitor |
| 08/06/2008 | EP1951200A2 Nanoemulsion compositions having anti-inflammatory activity |
| 08/06/2008 | EP1725581B1 Novel assay for the separation and quantification of hemagglutinin antigens |
| 08/06/2008 | EP1649287B1 Evaluation of adjuvanted vaccines |
| 08/06/2008 | EP1585546B1 Kim-1 antagonists and use to modulate immune system |
| 08/06/2008 | EP1508047B1 Method for identifying immunoreactive peptides |